Sorafenib Combined with Transarterial Chemoembolization versus Transarterial Chemoembolization Alone for Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Study

AIMS: The purpose of the present study was to compare the efficacies of transarterial chemoembolization (TACE) combined with sorafenib versus TACE monotherapy for treating patients with advanced hepatocellular carcinoma (HCC). METHODS: We enrolled 321 patients and selected 280 with advanced HCC (Bar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hao, Duan, Zhenhua, Long, Xiaoran, Hertzanu, Yancu, Shi, Haibin, Liu, Sheng, Yang, Zhengqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016022/
https://www.ncbi.nlm.nih.gov/pubmed/24817002
http://dx.doi.org/10.1371/journal.pone.0096620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016022/
https://www.ncbi.nlm.nih.gov/pubmed/24817002
http://dx.doi.org/10.1371/journal.pone.0096620

Ejemplares similares